Olle Bergman

Summary

Country: Sweden

Publications

  1. ncbi PITX3 polymorphism is associated with early onset Parkinson's disease
    Olle Bergman
    Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, P O Box 431, S 405 30 Goteborg, Sweden
    Neurobiol Aging 31:114-7. 2010
  2. ncbi Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?
    Olle Bergman
    Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, P O B 431, 40530, Gothenburg, Sweden
    J Neural Transm 116:333-8. 2009
  3. ncbi Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity
    Olle Bergman
    Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden
    Int J Neuropsychopharmacol 14:1367-76. 2011
  4. ncbi Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophrenia
    Olle Bergman
    Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    Prog Neuropsychopharmacol Biol Psychiatry 34:1094-7. 2010
  5. ncbi Cyclooxygenase-2 polymorphisms in Parkinson's disease
    Anna Håkansson
    Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    Am J Med Genet B Neuropsychiatr Genet 144:367-9. 2007

Detail Information

Publications5

  1. ncbi PITX3 polymorphism is associated with early onset Parkinson's disease
    Olle Bergman
    Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, P O Box 431, S 405 30 Goteborg, Sweden
    Neurobiol Aging 31:114-7. 2010
    ..002) or to PD patients with late onset (p=0.001). In contrast, a previous finding suggesting a SNP (rs3758549) in the putative promoter region of the PITX3 gene to be associated with PD could not be replicated...
  2. ncbi Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?
    Olle Bergman
    Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, P O B 431, 40530, Gothenburg, Sweden
    J Neural Transm 116:333-8. 2009
    ....
  3. ncbi Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity
    Olle Bergman
    Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden
    Int J Neuropsychopharmacol 14:1367-76. 2011
    ..The results highlight the importance of distinguishing between hyperactivity-impulsivity and inattention, respectively, and demonstrate the value of using a longitudinal approach in genetic studies of ADHD symptoms...
  4. ncbi Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophrenia
    Olle Bergman
    Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    Prog Neuropsychopharmacol Biol Psychiatry 34:1094-7. 2010
    ..Preliminary evidence that genetic variation in LMX1A (rs6668493, rs4657411), LMX1B (rs10987386) and PITX3 (rs4919621) may increase the risk of developing schizophrenia is presented...
  5. ncbi Cyclooxygenase-2 polymorphisms in Parkinson's disease
    Anna Håkansson
    Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    Am J Med Genet B Neuropsychiatr Genet 144:367-9. 2007
    ..007). In females no difference could be seen between PD-patients and controls. In conclusion, the results suggest a possible influence of the COX-2 C8473T SNP in PD, although it only seems to be of importance in men...